The study demonstrated that chemerin significantly increased the in vitro invasiveness of gastric cancer cells in Boyden chamber assays, with a 5-fold increase in migration at a chemerin concentration of 0.1 ng/mL, without affecting their proliferation. Here, RARRES2 is linked to gastric cancer.